BMI View: We see little prospect of the Irish government relenting its targeting the pharmaceuticals and
healthcare sector for cost savings in 2014. While Ireland successfully exited its EUR85bn bailout with the
EU/IMF in December 2013, the governing Fine Gael/Labour ..."
BMI View: Further negative developments have hit Ireland's pharmaceutical industry hard in recent
months, with exports of organic chemicals falling significantly in the wake of patent expirations. However,
we believe that the worst is largely over, as the impact of pa ..."
BMI View: A number of negative developments this quarter have led us to downgrade our pharmaceutical and healthcare forecasts. The establishment of a 'preferred drugs' list and implementation of the Health (Pricing and Supply of Medical Goods) Bill shows the government's determin ..."
THE PHARMACEUTICAL MARKET: IRELAND - REVIEW
Ireland has experienced rapid economic growth over the past 20 years, and has invested in large scale renovation and redevelopment of its healthcare infrastructure. That said, the country is in the midst of a severe economic downturn ..."